{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:12:57Z","timestamp":1791994377303,"version":"4.4.0"},"reference-count":122,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Med Res"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>Macular telangiectasia type 2 is a genetically complex disorder with variable penetrance and expressivity. Although several causative genes have been identified, the genetic basis remains unknown in most affected individuals. Genetic and metabolomic studies have implicated dysregulated serine and lipid metabolism in disease pathogenesis. Serine deficiency promotes the accumulation of cytotoxic 1-deoxysphingolipids, which damage M\u00fcller cells, photoreceptors, and retinal pigment epithelium. Emerging evidence suggests that the retinal pigment epithelium plays a more important role in disease development than previously recognized. Macular telangiectasia type 2 has traditionally been considered a primary neurodegenerative disorder with secondary vascular abnormalities. However, optical coherence tomography angiography findings have indicated that vascular changes may occur earlier than previously appreciated and may develop in parallel with neurodegeneration rather than as a secondary consequence. Furthermore, there is a strong structure\u2013function correlation between ellipsoid zone loss on optical coherence tomography and retinal sensitivity measured using microperimetry. This relationship supported the acceptance by the US Food and Drug Administration of ellipsoid zone loss area, a structural surrogate endpoint, for the approval of the ciliary neurotrophic factor implant (revakinagene taroretcel-Lwey) in macular telangiectasia type 2 patients. Several therapeutic strategies targeting the underlying metabolic abnormalities are also under investigation. These include serine supplementation, fenofibrate to reduce 1-deoxysphingolipid production, and gene replacement therapy. In addition, growing evidence suggests that mitochondrial dysfunction and impaired cellular energy metabolism contribute to disease pathogenesis and warrant further investigation as potential therapeutic targets.<\/jats:p>","DOI":"10.1177\/03000605261473180","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:09:53Z","timestamp":1785884993000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Macular telangiectasia type 2: An update"],"prefix":"10.1177","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3387-7058","authenticated-orcid":false,"given":"Lihteh","family":"Wu","sequence":"first","affiliation":[{"name":"Asociados de Macula"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3670-9129","authenticated-orcid":false,"given":"G\u00e9nesis","family":"Chen-Li","sequence":"additional","affiliation":[{"name":"Asociados de Macula"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Mar","family":"Sanabria","sequence":"additional","affiliation":[{"name":"Asociados de Macula"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2012.11.007"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2012.11.002"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20200108-05"},{"key":"e_1_3_2_5_2","volume-title":"Stereoscopic atlas of macular diseases: diagnosis and treatment. 2nd ed","author":"Gass JDM","year":"1977","unstructured":"Gass JDM. Stereoscopic atlas of macular diseases: diagnosis and treatment. 2nd ed. Louis: C. V. Mosby; 1977."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.03.040"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjo.2015.09.001"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.159864"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-023-00505-5"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2022.04.002"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000082"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001697"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-1749"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01723-7"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.06-1272"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-16915"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002694"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000003328"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000004681"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001728"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0636"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2021.03.022"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.04.030"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.3109\/09286580903450361"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2017.06.005"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2017.10.008"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002646"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.18-23886"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000003055"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(93)31447-8"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.07.025"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20140909-06"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000799"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.4274\/tjo.68335"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.19-27055"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002619"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2014.3950"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002289"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002986"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001694"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001344"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-20976"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-18872"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01699-4"},{"key":"e_1_3_2_45_2","article-title":"Reduced foveal cone density in early idiopathic macular telangiectasia","volume":"6","author":"Song H","year":"2021","unstructured":"Song H, Rossi EA, Williams DR. Reduced foveal cone density in early idiopathic macular telangiectasia. BMJ Open Ophthalmol 2021; 6: e000603.","journal-title":"BMJ Open Ophthalmol"},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9103149","article-title":"Topographic relationship between telangiectasia and cone mosaic disruption in macular telangiectasia type 2","volume":"9","author":"Zandi R","year":"2020","unstructured":"Zandi R, Song J, Micevych PS, et al. Topographic relationship between telangiectasia and cone mosaic disruption in macular telangiectasia type 2. J Clin Med 2020; 9: 3149.","journal-title":"J Clin Med"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000863"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-313364"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000038"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318285cb9c"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2019-315416"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259811"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-023-02453-8"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.02.023"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001715"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10580"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10765"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-019-04323-0"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-67801-4"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000004108"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.9.4.27"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-15576"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000365"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2025.11.008"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14110"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-318470"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.4.450"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2020.09.012"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1982.01030030773010"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3182695bb3"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001842"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181a4d2f1"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1080\/08820538.2021.1929347"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000004079"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-316021"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1159\/000442807"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000840"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2022.100261"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001860"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2023.09.016"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2025.101401"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2011-301009"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2011532117"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2841-12.2012"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-11559"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-12311"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23727"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1002\/glia.22477"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.117.6.821"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1969.00990020153002"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1177\/17590914221106903"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103691"},{"key":"e_1_3_2_93_2","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43598","article-title":"Human macular Muller cells rely more on serine biosynthesis to combat oxidative stress than those from the periphery","volume":"8","author":"Zhang T","year":"2019","unstructured":"Zhang T, Zhu L, Madigan MC, et al. Human macular Muller cells rely more on serine biosynthesis to combat oxidative stress than those from the periphery. elife 2019; 8: e43598.","journal-title":"elife"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.66.2.46"},{"key":"e_1_3_2_95_2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26020684","article-title":"Genetic background of macular telangiectasia type 2","volume":"26","author":"Kun\u010di\u010d A","year":"2025","unstructured":"Kun\u010di\u010d A, Urban\u010di\u010d M, Dobov\u0161ek Divjak D, et al. Genetic background of macular telangiectasia type 2. Int J Mol Sci 2025; 26: 684.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2018.3283"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000004052"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3799"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101716"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-021-00361-3"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1815111"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69164-y"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.788422"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2008.01.003"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.03.017"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0840-8"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39775-w"},{"key":"e_1_3_2_108_2","article-title":"iPSC-derived retinal pigmented epithelial cells from patients with macular telangiectasia show decreased mitochondrial function","volume":"133","author":"Eade KT","year":"2023","unstructured":"Eade KT, Ansell BRE, Giles S, et al. iPSC-derived retinal pigmented epithelial cells from patients with macular telangiectasia show decreased mitochondrial function. J Clin Invest 2023; 133: e163771.","journal-title":"J Clin Invest"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2024.100618"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M311830200"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000203"},{"key":"e_1_3_2_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2025.06.005"},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410350206"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.09.041"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2400481"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDe2500127"},{"key":"e_1_3_2_117_2","doi-asserted-by":"crossref","unstructured":"Chew EY Clemons TE Peto T et al. Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trial. Am J Ophthalmol 2015; 159: 659\u201366 e1.","DOI":"10.1016\/j.ajo.2014.12.013"},{"key":"e_1_3_2_118_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI57549"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2015.03.011"},{"key":"e_1_3_2_120_2","doi-asserted-by":"publisher","DOI":"10.7150\/thno.105299"},{"key":"e_1_3_2_121_2","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2024.1428777"},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4023"},{"key":"e_1_3_2_123_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-025-02269-8"}],"container-title":["Journal of International Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03000605261473180","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03000605261473180","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03000605261473180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:30:36Z","timestamp":1786120236000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03000605261473180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":122,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1177\/03000605261473180"],"URL":"https:\/\/doi.org\/10.1177\/03000605261473180","relation":{},"ISSN":["0300-0605","1473-2300"],"issn-type":[{"value":"0300-0605","type":"print"},{"value":"1473-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"article-number":"03000605261473180"}}